{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:43:03Z","timestamp":1793256183394,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005278","name":"Universidad de Antioquia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005278","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Exploratory Research in Clinical and Social Pharmacy"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.rcsop.2024.100524","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T22:58:43Z","timestamp":1728601123000},"page":"100524","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Effectiveness and safety of cannabis-based products for medical use in patients with fibromyalgia syndrome: A systematic review"],"prefix":"10.1016","volume":"16","author":[{"given":"Valentina","family":"Lopera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Restrepo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Amariles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rcsop.2024.100524_bb0005","series-title":"StatPearls","article-title":"Fibromyalgia","author":"Bhargava","year":"2024"},{"issue":"6","key":"10.1016\/j.rcsop.2024.100524_bb0010","first-page":"1205","article-title":"Fibromyalgia: one year in review 2023","volume":"41","author":"Giorgi","year":"2023","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"10.1016\/j.rcsop.2024.100524_bb0015","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41584-020-00506-w","article-title":"Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment","volume":"16","author":"Sarzi-Puttini","year":"2020","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"10.1016\/j.rcsop.2024.100524_bb0020","doi-asserted-by":"crossref","first-page":"570","DOI":"10.7861\/clinmed.2022-0402","article-title":"The diagnosis of fibromyalgia syndrome","volume":"22","author":"Berwick","year":"2022","journal-title":"Clin Med Lond Engl"},{"key":"10.1016\/j.rcsop.2024.100524_bb0025","series-title":"Fibromyalgia","author":"Mayo clinic","year":"2024"},{"key":"10.1016\/j.rcsop.2024.100524_bb0030","series-title":"Fibromyalgia Syndrome","first-page":"83","article-title":"Fibromyalgia: Classification, criteria, and diagnosis\u2014What is fibromyalgia?","author":"Tzadok","year":"2021"},{"issue":"9","key":"10.1016\/j.rcsop.2024.100524_bb0035","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/ejp.1252","article-title":"Comorbid fibromyalgia: a qualitative review of prevalence and importance","volume":"22","author":"Fitzcharles","year":"2018","journal-title":"Eur J Pain Lond Engl"},{"key":"10.1016\/j.rcsop.2024.100524_bb0040","series-title":"StatPearls","article-title":"Fibromyalgia","author":"Bhargava","year":"2024"},{"issue":"8","key":"10.1016\/j.rcsop.2024.100524_bb0045","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s11916-013-0356-5","article-title":"Worldwide epidemiology of fibromyalgia","volume":"17","author":"Queiroz","year":"2013","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.rcsop.2024.100524_bb0050","first-page":"7","article-title":"Chronic pain syndromes: fibromyalgia","volume":"533","author":"Flynn","year":"2023","journal-title":"FP Essent"},{"issue":"4","key":"10.1016\/j.rcsop.2024.100524_bb0055","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.mayocp.2024.02.016","article-title":"Is medical Cannabis a solution for controlling fibromyalgia symptoms?","volume":"99","author":"David","year":"2024","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"10.1016\/j.rcsop.2024.100524_bb0075","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.12939","article-title":"Comparison of amitriptyline and US Food and Drug Administration-approved treatments for fibromyalgia: a systematic review and network Meta-analysis","volume":"5","author":"Farag","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"7","key":"10.1016\/j.rcsop.2024.100524_bb0080","first-page":"CD011694","article-title":"Cannabinoids for fibromyalgia","volume":"7","author":"Walitt","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.rcsop.2024.100524_bb0085","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1080\/14656566.2024.2365326","article-title":"Pharmacotherapeutic advances in fibromyalgia: what\u2019s new on the horizon?","volume":"25","author":"Sarzi-Puttini","year":"2024","journal-title":"Expert Opin Pharmacother"},{"issue":"suppl 130","key":"10.1016\/j.rcsop.2024.100524_bb0090","doi-asserted-by":"crossref","first-page":"115","DOI":"10.55563\/clinexprheumatol\/qcyet7","article-title":"Use of medical cannabis by patients with fibromyalgia in Canada after cannabis legalisation: a cross-sectional study","volume":"39","author":"Fitzcharles","year":"2021","journal-title":"Clin Exp Rheumatol"},{"issue":"19","key":"10.1016\/j.rcsop.2024.100524_bb0095","doi-asserted-by":"crossref","first-page":"12106","DOI":"10.3390\/ijerph191912106","article-title":"Review of fibromyalgia (FM) syndrome treatments","volume":"19","author":"Cohen-Biton","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.rcsop.2024.100524_bb0100","author":"National Institute for Health and Care Excellence"},{"key":"10.1016\/j.rcsop.2024.100524_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108216","article-title":"Cannabinoids and the endocannabinoid system in fibromyalgia: a review of preclinical and clinical research","volume":"240","author":"Bourke","year":"2022","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.rcsop.2024.100524_bb0110","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.rcsop.2024.100524_bb0115","series-title":"MANUAL GRADE Grading of Recommendations, Assessment, Development and Evaluation Versi\u00f3n En Espa\u00f1ol 2017","author":"Sch\u00fcnemann","year":"2013"},{"issue":"2","key":"10.1016\/j.rcsop.2024.100524_bb0120","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1532-3382(01)70024-3","article-title":"Enhancing your practice through evidence-based decision making: PICO, learning how to ask good questions","volume":"1","author":"Miller","year":"2001","journal-title":"J Evid Based Dent Pract"},{"issue":"10","key":"10.1016\/j.rcsop.2024.100524_bb0125","first-page":"2212","article-title":"Ingestion of a THC-rich Cannabis oil in people with fibromyalgia: a randomized, double-blind, placebo-controlled clinical trial","volume":"21","author":"Chaves","year":"2020","journal-title":"Pain Med Malden Mass"},{"issue":"4","key":"10.1016\/j.rcsop.2024.100524_bb0130","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/j.pain.0000000000001464","article-title":"An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia","volume":"160","author":"van de Donk","year":"2019","journal-title":"Pain"},{"issue":"suppl 123","key":"10.1016\/j.rcsop.2024.100524_bb0135","first-page":"53","article-title":"Adding medical cannabis to standard analgesic treatment for fibromyalgia: a prospective observational study","volume":"38","author":"Giorgi","year":"2020","journal-title":"Clin Exp Rheumatol"},{"issue":"suppl 116","key":"10.1016\/j.rcsop.2024.100524_bb0140","first-page":"13","article-title":"Effect of adding medical cannabis to analgesic treatment in patients with low back pain related to fibromyalgia: an observational cross-over single Centre study","volume":"37","author":"Yassin","year":"2019","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.rcsop.2024.100524_bb0145","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1213\/ANE.0b013e3181c76f70","article-title":"The effects of nabilone on sleep in fibromyalgia: results of a randomized controlled trial","volume":"110","author":"Ware","year":"2010","journal-title":"Anesth Analg"},{"issue":"10","key":"10.1016\/j.rcsop.2024.100524_bb0150","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1097\/j.pain.0000000000001293","article-title":"Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies","volume":"159","author":"Stockings","year":"2018","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.rcsop.2024.100524_bb0155","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/rheumatology\/keaa534","article-title":"Cannabis use assessment and its impact on pain in rheumatologic diseases: a systematic review and meta-analysis","volume":"60","author":"Guillouard","year":"2021","journal-title":"Rheumatol Oxf Engl"},{"issue":"8","key":"10.1016\/j.rcsop.2024.100524_bb0160","article-title":"A systematic review of fibromyalgia and recent advancements in treatment: is medicinal Cannabis a new Hope?","volume":"13","author":"Khurshid","year":"2021","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.rcsop.2024.100524_bb0165","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.3390\/biomedicines11061621","article-title":"Cannabis for the treatment of fibromyalgia: a systematic review","volume":"11","author":"Strand","year":"2023","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.rcsop.2024.100524_bb0170","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1089\/acm.2020.0331","article-title":"Safety and efficacy of medicinal Cannabis in the treatment of fibromyalgia: a systematic review","volume":"27","author":"Kurlyandchik","year":"2021","journal-title":"J Altern Complement Med N Y N"},{"issue":"1","key":"10.1016\/j.rcsop.2024.100524_bb0175","first-page":"47","article-title":"Efficacy, tolerability and safety of cannabinoids in chronic pain associated with rheumatic diseases (fibromyalgia syndrome, back pain, osteoarthritis, rheumatoid arthritis): a systematic review of randomized controlled trials","volume":"30","author":"Fitzcharles","year":"2016","journal-title":"Schmerz Berl Ger"},{"issue":"4","key":"10.1016\/j.rcsop.2024.100524_bb0180","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s40122-022-00434-5","article-title":"Systematic review and Meta-analysis seem to indicate that cannabinoids for chronic primary pain treatment have limited benefit","volume":"11","author":"Giossi","year":"2022","journal-title":"Pain Ther"},{"issue":"5","key":"10.1016\/j.rcsop.2024.100524_bb0185","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/acr.22727","article-title":"Efficacy, tolerability, and safety of cannabinoid treatments in the rheumatic diseases: a systematic review of randomized controlled trials","volume":"68","author":"Fitzcharles","year":"2016","journal-title":"Arthritis Care Res"},{"issue":"5","key":"10.1016\/j.rcsop.2024.100524_bb0190","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1365-2125.2011.03970.x","article-title":"Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials","volume":"72","author":"Lynch","year":"2011","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.rcsop.2024.100524_bb0195","first-page":"CD012182","article-title":"Cannabis-based medicines for chronic neuropathic pain in adults","volume":"3","author":"M\u00fccke","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.rcsop.2024.100524_bb0200","first-page":"449","article-title":"The powers of flowers: evaluating the impact of floral therapy on pain and psychiatric symptoms in fibromyalgia","volume":"21","author":"Yavne","year":"2019","journal-title":"Isr Med Assoc J IMAJ"},{"issue":"8","key":"10.1016\/j.rcsop.2024.100524_bb0205","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/rapm-2020-101547","article-title":"Sharing the pain: an observational analysis of twitter and pain in Ireland","volume":"45","author":"Mullins","year":"2020","journal-title":"Reg Anesth Pain Med"},{"issue":"1","key":"10.1016\/j.rcsop.2024.100524_bb0210","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13063-023-07078-6","article-title":"Cannabis-opioid interaction in the treatment of fibromyalgia pain: an open-label, proof of concept study with randomization between treatment groups: cannabis, oxycodone or cannabis\/oxycodone combination-the SPIRAL study","volume":"24","author":"van Dam","year":"2023","journal-title":"Trials"},{"issue":"2","key":"10.1016\/j.rcsop.2024.100524_bb0215","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1089\/can.2021.0156","article-title":"Clinical practice guidelines for Cannabis and cannabinoid-based medicines in the Management of Chronic Pain and co-Occurring Conditions","volume":"9","author":"Bell","year":"2024","journal-title":"Cannabis Cannabinoid Res"},{"issue":"6","key":"10.1016\/j.rcsop.2024.100524_bb0220","article-title":"Plasma and interstitial levels of endocannabinoids and N-acylethanolamines in patients with chronic widespread pain and fibromyalgia: a systematic review and meta-analysis","volume":"7","author":"Kurlyandchik","year":"2022","journal-title":"Pain Rep"},{"issue":"3","key":"10.1016\/j.rcsop.2024.100524_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089566","article-title":"Care and feeding of the endocannabinoid system: a systematic review of potential clinical interventions that upregulate the endocannabinoid system","volume":"9","author":"McPartland","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.rcsop.2024.100524_bb0230","article-title":"Efficacy of Cannabis Flos in patients with fibromyalgia: a monocentric observational study","volume":"28","author":"Chiara Gerardi","year":"2016","journal-title":"ACR Meeting Abstracts September"},{"issue":"2","key":"10.1016\/j.rcsop.2024.100524_bb0235","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jpain.2007.09.002","article-title":"Nabilone for the treatment of pain in fibromyalgia","volume":"9","author":"Skrabek","year":"2008","journal-title":"J Pain"},{"issue":"4","key":"10.1016\/j.rcsop.2024.100524_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018440","article-title":"Cannabis use in patients with fibromyalgia: effect on symptoms relief and health-related quality of life","volume":"6","author":"Fiz","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.rcsop.2024.100524_bb0245","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3390\/jcm8060807","article-title":"Safety and efficacy of medical Cannabis in fibromyalgia","volume":"8","author":"Sagy","year":"2019","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.rcsop.2024.100524_bb0250","first-page":"281","article-title":"Medical Cannabis for the treatment of fibromyalgia","volume":"24","author":"Crestani","year":"2018","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"issue":"1","key":"10.1016\/j.rcsop.2024.100524_bb0255","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s42238-021-00060-6","article-title":"Medical cannabis for the treatment of fibromyalgia syndrome: a retrospective, open-label case series","volume":"3","author":"Mazza","year":"2021","journal-title":"J Cannabis Res."},{"issue":"7","key":"10.1016\/j.rcsop.2024.100524_bb0260","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1185\/030079906X112651","article-title":"Delta-9-THC based monotherapy in fibromyalgia patients on experimentally induced pain, axon reflex flare, and pain relief","volume":"22","author":"Schley","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.rcsop.2024.100524_bb0265","article-title":"Tetrahydrocannabinol (Delta 9-THC) treatment in chronic central neuropathic pain and fibromyalgia patients: results of a multicenter survey","volume":"2009","author":"Weber","year":"2009","journal-title":"Anesthesiol Res Pract"},{"issue":"7","key":"10.1016\/j.rcsop.2024.100524_bb0270","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.3072","article-title":"Assessment of clinical outcomes in patients with fibromyalgia: analysis from the UK medical Cannabis registry","volume":"13","author":"Wang","year":"2023","journal-title":"Brain Behav"},{"issue":"7","key":"10.1016\/j.rcsop.2024.100524_bb0275","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1097\/j.pain.0000000000002510","article-title":"Potential role of blood biomarkers in patients with fibromyalgia: a systematic review with meta-analysis","volume":"163","author":"Kumbhare","year":"2022","journal-title":"PAIN"},{"issue":"6","key":"10.1016\/j.rcsop.2024.100524_bb0280","first-page":"1521","article-title":"Are OMERACT recommendations followed in clinical trials on fibromyalgia? A systematic review of patient-reported outcomes and their measures","volume":"32","author":"D\u00f6hmen","year":"2023","journal-title":"Qual Life Res Int J Qual Life Asp Treat Care Rehabil"},{"issue":"5","key":"10.1016\/j.rcsop.2024.100524_bb0285","first-page":"728","article-title":"The fibromyalgia impact questionnaire: development and validation","volume":"18","author":"Burckhardt","year":"1991","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.rcsop.2024.100524_bb0290","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/bcpt.13710","article-title":"A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD)","volume":"130","author":"Peng","year":"2022","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"7","key":"10.1016\/j.rcsop.2024.100524_bb0295","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.3390\/molecules28073271","article-title":"The Polypharmacological effects of Cannabidiol","volume":"28","author":"Castillo-Arellano","year":"2023","journal-title":"Molecules"},{"issue":"22","key":"10.1016\/j.rcsop.2024.100524_bb0300","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228870","article-title":"Cannabidiol for pain treatment: focus on pharmacology and mechanism of action","volume":"21","author":"Mlost","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.rcsop.2024.100524_bb0305","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.3390\/jcm11051154","article-title":"Clinical relevance of drug interactions with Cannabis: a systematic review","volume":"11","author":"Lopera","year":"2022","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.rcsop.2024.100524_bb0310","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/smi.3071","article-title":"Associations of cannabis use, opioid use, and their combination with serious psychological distress among Ontario adults","volume":"38","author":"Nigatu","year":"2022","journal-title":"Stress Health J Int Soc Investig Stress"},{"issue":"23","key":"10.1016\/j.rcsop.2024.100524_bb0315","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1001\/jama.2018.17329","article-title":"States move to substitute opioids with medical marijuana to quell epidemic","volume":"320","author":"Voelker","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.rcsop.2024.100524_bb0320","author":"Knop Laboratorios"},{"issue":"1","key":"10.1016\/j.rcsop.2024.100524_bb0325","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s42238-024-00220-4","article-title":"Evaluation of dispensaries\u2019 cannabis flowers for accuracy of labeling of cannabinoids content","volume":"6","author":"Geweda","year":"2024","journal-title":"J Cannabis Res"}],"container-title":["Exploratory Research in Clinical and Social Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276624001215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276624001215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T23:06:40Z","timestamp":1762643200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667276624001215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":62,"alternative-id":["S2667276624001215"],"URL":"https:\/\/doi.org\/10.1016\/j.rcsop.2024.100524","relation":{},"ISSN":["2667-2766"],"issn-type":[{"value":"2667-2766","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness and safety of cannabis-based products for medical use in patients with fibromyalgia syndrome: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Exploratory Research in Clinical and Social Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rcsop.2024.100524","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100524"}}